Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C13H11N3.H2O4S |
| Molecular Weight | 516.572 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.NC1=CC2=NC3=CC(N)=CC=C3C=C2C=C1.NC4=CC5=NC6=CC(N)=CC=C6C=C5C=C4
InChI
InChIKey=YADYXCVYLIKQJX-UHFFFAOYSA-N
InChI=1S/2C13H11N3.H2O4S/c2*14-10-3-1-8-5-9-2-4-11(15)7-13(9)16-12(8)6-10;1-5(2,3)4/h2*1-7H,14-15H2;(H2,1,2,3,4)
| Molecular Formula | H2O4S |
| Molecular Weight | 98.078 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C13H11N3 |
| Molecular Weight | 209.2465 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.drugbank.ca/drugs/DB01123Curator's Comment: description was created based on several sources, including
https://www.drugs.com/uk/proflavine-cream-0-1-leaflet.html | https://www.ncbi.nlm.nih.gov/pubmed/22594981 | https://clinicaltrials.gov/ct2/show/NCT02029937
Sources: https://www.drugbank.ca/drugs/DB01123
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/uk/proflavine-cream-0-1-leaflet.html | https://www.ncbi.nlm.nih.gov/pubmed/22594981 | https://clinicaltrials.gov/ct2/show/NCT02029937
Proflavine is an acriflavine derivative used as a topical disinfectant agains gram-positive bacteria. Proflavine is toxic and carcinogenic in mammals and so it is used only as a surface disinfectant or for treating superficial wounds. Proflavine acts by interchelating DNA (intercalation), thereby disrupting DNA synthesis and leading to high levels of mutation in the copied DNA strands. This prevents bacterial reproduction. Proflavine was investigated for photodynamic theraphy of herpes but was discontinued due to several presentations of post-treatment Bowen's disease and higher lesion recrudescence periods. Proflavine is also investigated as a topical contrast agent for imaging and diagnosis of esophageal, oral, colon, cervical, uterine cancer and polyps.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3140325 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19364280 |
|||
Target ID: CHEMBL2311222 Sources: https://www.ncbi.nlm.nih.gov/pubmed/5341263 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | PROFLAVINE CREAM 0.1% Approved UseFor treatment of infected wounds and for skin disinfection |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Diagnostic | Unknown Approved UseUnknown |
|||
| Diagnostic | Unknown Approved UseUnknown |
|||
| Diagnostic | Unknown Approved UseUnknown |
|||
| Diagnostic | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Magnetic field effect corroborated with docking study to explore photoinduced electron transfer in drug-protein interaction. | 2010-12-30 |
|
| Synthesis, characterization and cytotoxicity studies of palladium(II)-proflavine complexes. | 2010-11 |
|
| Interaction of bioactive coomassie brilliant blue g with protein: insights from spectroscopic methods. | 2010-08-26 |
|
| Change of the binding mode of the DNA/proflavine system induced by ethanol. | 2010-07-01 |
|
| A fiber-optic fluorescence microscope using a consumer-grade digital camera for in vivo cellular imaging. | 2010-06-23 |
|
| The nature of the force-induced conformation transition of dsDNA studied by using single molecule force spectroscopy. | 2010-06-15 |
|
| "Weighing" photon energies with mass spectrometry: effects of water on ion fluorescence. | 2010-05-26 |
|
| Toxicology and drug delivery by cucurbit[n]uril type molecular containers. | 2010-05-06 |
|
| Design and evaluation of an ultra-slim objective for in-vivo deep optical biopsy. | 2010-03-01 |
|
| [Experimental study of proflavine acetate phototransformation processes]. | 2010-01-06 |
|
| Triple dye plus rubbing alcohol versus triple dye alone for umbilical cord care. | 2010-01 |
|
| [Features of binding of proflavine to DNA at different DNA-ligand concentration ratios]. | 2009-11-10 |
|
| Equine rhinitis A virus and its low pH empty particle: clues towards an aphthovirus entry mechanism? | 2009-10 |
|
| [Catalytical properties of the liver monoamine oxidases of the commander squid Berryteuthis magister from various habitation zones]. | 2009-09-22 |
|
| Stacking interactions and DNA intercalation. | 2009-08-13 |
|
| Abstracts of the 2008 ISSOL Meeting. August 24-29, 2008. Florence, Italy. | 2009-08 |
|
| 1H and 13C NMR signal assignments of some new N,N'-diacyl proflavine derivatives. | 2009-08 |
|
| Isothermal microcalorimetry to investigate non specific interactions in biophysical chemistry. | 2009-07-28 |
|
| Precambrian lunar volcanic protolife. | 2009-06-11 |
|
| Photo-inducible cytotoxic and clastogenic activities of 3,6-di-substituted acridines obtained by acylation of proflavine. | 2009-06 |
|
| Complexation of biologically active aromatic compounds with DNA in the presence of theophylline. | 2009-05 |
|
| Solution structure and thermodynamics of 2',5' RNA intercalation. | 2009-04-29 |
|
| Interaction of small molecules with double-stranded RNA: spectroscopic, viscometric, and calorimetric study of hoechst and proflavine binding to PolyCG structures. | 2009-04 |
|
| Fluorophore labeling to monitor tRNA dynamics. | 2009 |
|
| Skipjack tuna (Katsuwonus pelamis) liver monoamine oxidase: substrate-inhibitor analysis. | 2008-10-16 |
|
| Pyrrolo-C as a molecular probe for monitoring conformations of the tRNA 3' end. | 2008-10 |
|
| Electroanalytical study of proflavine intercalation in 5-methyl or inosine-containing amplicons. | 2008-10 |
|
| QacR-cation recognition is mediated by a redundancy of residues capable of charge neutralization. | 2008-08-05 |
|
| Conformational dynamics at the active site of alpha-chymotrypsin and enzymatic activity. | 2008-08-05 |
|
| Colicin E3 cleavage of 16S rRNA impairs decoding and accelerates tRNA translocation on Escherichia coli ribosomes. | 2008-07 |
|
| Role of the third strand in the binding of proflavine and pt-proflavine to poly(rA).2poly(rU): a thermodynamic and kinetic study. | 2008-06-12 |
|
| Self-structure induction in single stranded poly(A) by small molecules: Studies on DNA intercalators, partial intercalators and groove binding molecules. | 2008-06-01 |
|
| Complexation and fluorescence of tricyclic basic dyes encapsulated in cucurbiturils. | 2008-04-04 |
|
| Cytotoxic activity of proflavine diureas: synthesis, antitumor, evaluation and DNA binding properties of 1',1''-(acridin-3,6-diyl)-3',3''-dialkyldiureas. | 2008-04-01 |
|
| Label free electrochemical DNA hybridization discrimination effects at the binary and ternary mixed monolayers of single stranded DNA/diluent/s in presence of cationic intercalators. | 2008-03-14 |
|
| Over-expression of genes coding for proline oxidase, riboflavin kinase, cytochrome c oxidase and an MFS transporter induced by acriflavin in Trichophyton rubrum. | 2008-03 |
|
| Spectroscopic studies on ligand-enzyme interactions: complexation of alpha-chymotrypsin with 4',6-diamidino-2-phenylindole (DAPI). | 2008-02-14 |
|
| A randomised controlled trial of a double layer of Allevyn compared to Jellonet and proflavin as a tie-over dressing for small skin grafts. | 2008 |
|
| DNA binding by a new metallointercalator that contains a proflavine group bearing a hanging chelating unit. | 2008 |
|
| [Comparative toxicity of photosensitizers in varying destruction]. | 2007-12-07 |
|
| Protonation linked equilibria and apparent affinity constants: the thermodynamic profile of the alpha-chymotrypsin-proflavin interaction. | 2007-12 |
|
| Catalytic properties of monoamine oxidase from mink (Mustela vison) liver. | 2007-10-16 |
|
| Ligand-transporter interaction in the AcrB multidrug efflux pump determined by fluorescence polarization assay. | 2007-10-16 |
|
| Quantifying RNA-peptide interaction by single-quantum dot-based nanosensor: an approach for drug screening. | 2007-10-15 |
|
| Characterization of the multidrug efflux regulator AcrR from Escherichia coli. | 2007-09-14 |
|
| Fluorescent labeling of tRNAs for dynamics experiments. | 2007-09 |
|
| On the origin of the decrease in stability of the DNA hairpin d(GCGAAGC) on complexation with aromatic drugs. | 2007-08 |
|
| A rare cause of breast mass that mimics carcinoma: Foreign body reaction to amorphous surgical material. | 2007 |
|
| Progressing single biomolecule force spectroscopy measurements for the screening of DNA binding agents. | 2005-10 |
|
| Amino acridines action on Friend's retrovirus in relation to their molecular ionization. | 1989 |
Patents
Sample Use Guides
Proflavine cream 0.1% is indicated for topical use, to be applied to the affected part 2 - 3 times daily.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13654729
The minimal inhibition concentration (MIC) of proflavine with respect to various E.coli strains was determined by the twofold dilution method with LB agar containing the proflavine. Bacterial growth was recorded after 18 to 24 h of incubation at 37°C. Proflavine was effective in supressing bacterial growth at 6.5-12.5 ug/mL.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:34:43 GMT 2025
by
admin
on
Mon Mar 31 17:34:43 GMT 2025
|
| Record UNII |
27V8M747VB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
689004
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
27V8M747VB
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
1811-28-5
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
27V8M747VB
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
C84109
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
9849425
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
DBSALT001573
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
8724
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID4043777
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
759900
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
100000085103
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
SUB04058MIG
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY | |||
|
217-320-3
Created by
admin on Mon Mar 31 17:34:43 GMT 2025 , Edited by admin on Mon Mar 31 17:34:43 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |